Tofacitinib
- Strength
- 5 mg/1
- Form
- Tablet, Film Coated
- Class
- Janus Kinase Inhibitor
AvKARE
XELJANZ XR
tofacitinib
Listed by U.S. Pharmaceuticals
- Strength
- 22 mg/1
- Form
- Tablet, Extended Release
- Route
- Oral
- Class
- Janus Kinase Inhibitor
What it contains
- Tofacitinib Citrate 22 mg/1
FDA record
| Dosage form | Tablet, Extended Release |
|---|---|
| Route | Oral |
| Drug class | Janus Kinase Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 63539-502 |
| FDA application | NDA208246 |
| RxNorm concept | 1357541 |
| Package sizes listed | 1 |
| Marketed since | January 2020 |
Other products containing Tofacitinib
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Tofacitinib
- Strength
- 10 mg/1
- Form
- Tablet, Film Coated
- Class
- Janus Kinase Inhibitor
Macleods Pharmaceuticals Limited
TOFACITINIB
- Strength
- 5 mg/1
- Form
- Tablet, Film Coated
- Class
- Janus Kinase Inhibitor
Micro Labs Limited
TOFACITINIB
- Strength
- 10 mg/1
- Form
- Tablet, Film Coated
- Class
- Janus Kinase Inhibitor
Micro Labs Limited
Tofacitinib
- Strength
- 11 mg/1
- Form
- Tablet, Film Coated, Extended Release
- Class
- Janus Kinase Inhibitor
Edenbridge Pharmaceuticals LLC.
Tofacitinib
- Strength
- 10 mg/1
- Form
- Tablet, Film Coated
- Class
- Janus Kinase Inhibitor
Apotex Corp.
tofacitinib
- Strength
- 22 mg/1
- Form
- Tablet, Film Coated, Extended Release
- Class
- Janus Kinase Inhibitor
Zydus Lifesciences Limited
TOFACITINIB
- Strength
- 11 mg/1
- Form
- Tablet, Film Coated, Extended Release
- Class
- Janus Kinase Inhibitor
Orient Pharma Co., Ltd. Yunlin Plant
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.